“Accounting for the Widening Mortality Gap between American Adults with and without a BA” by Anne Case and Angus Deaton

Is private equity good for healthcare?

Managing the privacy challenge in e-health policies: A discussion

A Pooled Investment Fund to finance innovation in pediatric oncology through a portfolio of independent development trajectories

Speaker:

Sam Daems
Investment Director
Waterland

Join us onsite on ULB Campus Solbosch – Building H, Room H3.366 (please confirm your attendance to Naomi Friedlaender by April 13: nfriedlaender@i3health.eu)

or Online via Zoom: Register here

The Impact of Mindfulness on Organizational Control Mechanisms : A Transdisciplinary Theoretical Framework

“Orphan drugs, clinical uncertainty and prices: Addressing allocative and technical inefficiencies in orphan drug reimbursement”
(H. G Eichler, M. Kossmeier, M. Zeitlinger, & B. Schwarzer-Daum)

Michel Goldman,
Founding President, I3h Institute, ULB

Member of the Advisory Forum to the European Health Emergency Preparedness and Response Authority (HERA)

Join us onsite on ULB Campus Solbosch – Building H, Room H3.366 (please confirm your attendance to Naomi Friedlaender by February 9: nfriedlaender@i3health.eu)

or Online via Zoom: Register here

Bram De Rock, Vice-dean of research at SBS-EM, Director of ECARES and Full professor at ULB and KU Leuven

Join us onsite on ULB Campus Solbosch – Building H, Room H3.366 (please confirm your attendance to Naomi Friedlaender by December 14: nfriedlaender@i3health.eu)

or Online via Zoom: Register here

James Robinson, Professor of Health Economics in the School of Public Health at the University of California, Berkeley

Join us onsite on ULB Campus Solbosch – Building H, Room H3.366 (please confirm your attendance to Naomi Friedlaender by December 12: nfriedlaender@i3health.eu)

or Online via Zoom: Register here

Ilaria Natali, Post-Doc, University of Toulouse and PhD, ECARES (ULB)

Join us onsite on ULB Campus Solbosch – Building H, Room H3.366 (please confirm your attendance to Naomi Friedlaender by November 16: nfriedlaender@i3health.eu)

or Online via Zoom: Register here

WILLEMINE WILLEMS Postdoctoral Researcher and Lecturer at Athena Institute, Vrije Universiteit Amsterdam

Online: Register via Zoom: here

DENIS HERBAUX Solvay Brussels School of Economics and Management ; PAQS asbl

Online: Register via Zoom: here

GUILHEM CASSAN Associate Professor, University of Namur

• Online: Register via Zoom: here

MATHIAS DEWATRIPONT Co-Director, I3h Institute (ULB)

• Online: Register via Zoom: here
• On-site: ULB Campus Solbosch (Av. Paul Héger 6, Building H, room H.3.366)

MARISA MIRALDO Associate Professor in Health Economics, Imperial College London

LUC DEBRUYNE Strategic Advisor at the Coalition for Epidemic Preparedness Innovations (CEPI); Former President of GSK Global Vaccines

CHARLES WYPLOSZ Emeritus Professor at the Graduate Institute in Geneva, Editor of Covid Economics at the Centre for Economic Policy Research

ANTONIO ESTACHE Professor of Economics, Université Libre de Bruxelles, Belgium; Research Fellow, European Center for Advanced Research in Economics and Statistics (ECARES), Brussels

PHILIP VERWIMP Member of the ECARES, Solvay Brussels School of Economics and Management, I3h Institute; Co-director, Households in Conflict Network

PHILIPPE BEUTELS Scientific director of the Centre for Health Economics Research & Modeling Infectious Diseases (CHERMID) of the Vaccine & Infectious Disease Institute (University of Antwerp)

OLIVIER VANDENBERG School of Public Health, Université Libre de Bruxelles (ULB); Division of Infection & Immunity, UCL, London, UK

JEAN-MICHEL DOGNÉ Head of the Department of Pharmacy at the University of Namur, Member of the EMA’s Pharmacovigilance Risk Assessment Committee and WHO’s Global Advisory Committee on Vaccine Safety

SEVGI YUKSEL Assistant Professor of Economics at University of California Santa Barbara
REGISTRATION

LYDIE MEHEUS Managing Director, Anticancer Fund
REGISTRATION

SANDY TUBEUF Professor of Health Economics, UCLouvain
REGISTRATION

Iris Kesternich Professor of Behavioral Economics, KU Leuven

Marius Gilbert  Head of the Spatial Epidemiology Lab, ULB Research director at FNRS-FRSS

Jean-Louis Vanherweghem  Professor Emeritus of the ULB, Member of the Royal Academy of Medicine

Marius Gilbert  FNRS Research director at the ULB Head of the spatial epidemiology Lab Member of the former GEES

Niel Hens  Professor at UAntwerpen and UHasselt, Member of the former Group of Experts for the Exit Strategy (GEES)s

Ri De Ridder  former director-general at the National Institute for Health and Disability Insurance (Inami/Riziv), i.a. managing the medicines reimbursement process, and current president on the board of directors for Doctors of the World Belgium

Jeroen Luyten  Associate Professor of Health Economics at the Leuven Institute for Healthcare Policy and a visiting fellow at the London School of Economics

Giovanni Briganti  Associate Lecturer of Medical Technology (AI & Health) at ULB and Lecturer of Physiology at the ES Santé School of Health

Antoine Dechezleprêtre  Senior Economist at OECD

Mathias Dewatripont  Former Executive Director of the National Bank of Belgium and Dean of the Solvay Brussels School of Economics and Management

Link to the presentation

Bram De Rock  Professor in Mathematical Economics at ULB and KU Leuven; Director of ECARES

Vincent Lorant  Professor at Faculty of Public Health, UCL

Antoine Dechezleprêtre  Senior Economist at OECD

Marie Neunez  Research fellow at Institute for Interdisciplinary Innovation in healthcare (I3h)

Sofia Amaral-Garcia Postdoc Researcher at Hasselt University, in the research group Economics and Public Policy

Ilaria Natali Teaching Assistant for Advanced Industrial Organization, ULB

Philippe Van Wilder Professor in health economics and HTA at Ecole de Santé Publique, ULB

Raf Van Gestel Assistant Professor, Erasmus School of Economics & Erasmus School of Health Policy and Management

Lynda Grine Doctor-assistant at Ghent University and Research Associate at the Dermatology Department of Ghent University Hospital

Bob Blasdel Research Director for Vesale Pharma